Market Cap

MorphoSys AG Market Capitalization:

€2.55 Billion

EUR as of July 1, 2024

US$2.74 Billion

business MorphoSys AG Company Profile

MorphoSys AG Main Stock Listings

Market Capitalization History of MorphoSys AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of MorphoSys AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 €1.33 B 139.97%
Jan. 1, 2023 €555.5 M -41.90%
Jan. 1, 2022 €956.2 M -71.81%
Jan. 1, 2021 €3.39 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

MorphoSys AG Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

MorphoSys AG has the following listings and related stock indices.


Stock: FSX: MOR

Stock: FSX: MOR2

Stock: XETR: MOR

Stock: NASDAQ: MOR

Stock: OTC: MPSYF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.